Source: Eur Respir J 2011; 38: 939-946
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Martin C., Thévenot G., Danel S., Chapron J., Tazi A., Macey J., Dusser D.J., Fajac I., Burgel P-R.. Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur Respir J 2011; 38: 939-946

Member's Comments

No comment yet.

Related content which might interest you: Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro Source: Eur Respir J 2002; 20: 1449-1456 Year: 2002 CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium Source: Eur Respir J 2013; 42: 1553-1562 Year: 2013 Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor Source: Eur Respir J 2008; 31: 714-724 Year: 2008 Imbalance between vascular endothelial growth factor and endostatin in emphysema Source: Eur Respir J 2003 Oct 01;22(4):609-612 Year: 2003 PTEN reduces vascular endothelial growth factor–mediated vascular permeability in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 581s Year: 2005 Role of corticosteroids in TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells Source: Annual Congress 2003 - Cell signalling and cytokines in asthma Year: 2003 Interactions of connective tissue growth factor and vascular endothelial growth factor in human airway smooth muscle Source: Eur Respir J 2004; 24: Suppl. 48, 454s Year: 2004 Effect of dexamethasone on TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells - role of histone-acetylation Source: Eur Respir J 2004; 24: Suppl. 48, 695s Year: 2004 Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia Source: Eur Respir J 2001; 17: 681-687 Year: 2001 Vascular endothelial growth factor (VEGF) isoform expression in primary human cultured alveolar epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 84s Year: 2003 Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006 A role for vascular endothelial growth factor (VEGF) in fibrosis? Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 Vascular endothelial growth factor (VEGF) , a specific marker of angiogenesis, is increased in asthmatic airways following allergen challenge Source: Eur Respir J 2004; 24: Suppl. 48, 227s Year: 2004 Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma Year: 2004 Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003 The effect of vascular endothelial growth factor (VEGF) on primary human cultured type 2 alveolar epithelial (AE2) cell proliferation Source: Annual Congress 2004 - Cellular injury and repair in the lung Year: 2004 The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats Source: Eur Respir J 2007; 30: 31-39 Year: 2007